Citius Pharmaceuticals Inc (CTXR) stock has gained 74.77% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CTXR stock a score of 70 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 84. In addition to the average rating from Wall Street analysts, CTXR stock has a mean target price of 6. This means analysts expect the stock to rise 209.28% over the next 12 months. CTXR's rank also includes a long-term technical score of 80. The short-term technical score for CTXR is 45.
What's Happening with CTXR Stock Today
Citius Pharmaceuticals Inc (CTXR) stock is down -7.08% while the S&P 500 has gained 1.04% as of 11:49 AM on Thursday, May 13. CTXR is lower by -$0.15 from the previous closing price of $2.09 on volume of 4,220,821 shares. Over the past year the S&P 500 is up 45.58% while CTXR has gained 74.77%. CTXR lost -$0.47 per share in the over the last 12 months.